Infliximab in the treatment of persistently active refractory juvenile idiopathic (chronic) arthritis: A short-term pilot study.

被引：0
|
作者：
Gerloni, V
Pontikaki, I
Desiati, F
Gattinara, M
Fantini, F
机构：
来源：
ARTHRITIS AND RHEUMATISM | 2000年 / 43卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1139
引用
收藏
页码：S256 / S256
页数：1
相关论文
共 50 条
  • [1] Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy
    De Marco, G.
    Gerloni, V.
    Pontikaki, I.
    Lurati, A.
    Teruzzi, B.
    Salmaso, A.
    Valcamonica, E.
    Gattinara, M.
    Fantini, F.
    REUMATISMO, 2007, 59 (01) : 50 - 56
  • [2] Long-term evaluation of efficacy and safety of infliximab in the treatment of persistently active juvenile idiopathic arthritis (JIA), refractory to standard treatments
    Gerloni, V
    Pontikaki, I
    De Marco, G
    Valcamonica, E
    Gattinara, M
    Teruzzi, B
    Lurati, A
    Salmaso, A
    Fantini, F
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 515 - 515
  • [3] Infliximab treatment in the refractory chronic uveitis of juvenile idiopathic arthritis (JLA).
    Honkanen, V
    Lappi, M
    Koskinen, L
    Lindahl, P
    Lahdenne, P
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S292 - S292
  • [4] Long-term evaluation (efficacy and safety) of infliximab in the treatment of persistently active juvenile idiopathic arthritis (JIA), refractory to standard treatments.
    Gerloni, V
    Pontikaki, I
    De Marco, G
    Gattinara, M
    Valcamonica, E
    Lurati, A
    Salmaso, A
    Teruzzi, B
    Fantini, F
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S84 - S84
  • [5] Infliximab in the treatment of refractory juvenile idiopathic arthritis.
    Masatlioglu, S
    Gogus, F
    Cevirgen, D
    Seyahi, E
    Hatemi, G
    Ozdogan, H
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S481 - S481
  • [6] Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis
    Tynjala, Pirjo
    Lindahl, Paivi
    Honkanen, Visa
    Lahdenne, Pekka
    Kotaniemi, Kaisu
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (04) : 548 - 550
  • [7] Short-term treatment with infliximab in chronic refractory pouchitis and ileitis
    Calabrese, C.
    Gionchetti, P.
    Rizzello, F.
    Liguori, G.
    Gabusi, V.
    Tambasco, R.
    Poggioli, G.
    Pierangeli, F.
    Campieri, M.
    Di Febo, G.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (09) : 759 - 764
  • [8] Efficacy of infusions of an anti Tnfα antibody (infliximab) in persistently active refractory juvenile idiopathic arthritis. results of a two years open label prospective study.
    Gerloni, V
    Lurati, A
    Gattinara, M
    Pontikaki, I
    Fantini, F
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S92 - S92
  • [9] Adalimumab in the treatment of juvenile idiopathic arthritis associated uveitis -: A pilot study.
    Tynjala, Pirjo
    Kotaniemi, Kaisu
    Lindahl, Paivi
    Latva, Katariina
    Aalto, Kristiina
    Honkanen, Visa
    Lahdenne, Pekka
    ARTHRITIS AND RHEUMATISM, 2006, 54 (12): : 4034 - 4034
  • [10] Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor a monoclonal antibody, infliximab, in persistently active refractory juvenile idiopathic (chronic) arthritis
    Gerloni, V
    Pontikaki, I
    Lurati, A
    Demarco, G
    Fantini, F
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 286 - 286
12345